Using Venture Capital to Improve Army Research and Development

2000 ◽  
Author(s):  
Bruce Held ◽  
◽  
Ike Chang
Author(s):  
Michael Kinch

Despite and arguably because of the enormous public health benefits arising from the introduction of new medicines, the industry is in the midst of crisis. We detail in this chapter the decline in research and development efficiency, which has been termed “Eroom's Law,” a playful inversion of the bettern known Moore's Law of Computing. An explanation of declining efficiency follows as is a brief summary of some remedies taken by many biopharmaceutical entities, including the abandonment of therapeutics targeting particularly difficult indications such as Alzheimer's disease and antibiotics. We also convey how the industry has developed into a sort of food chain, with smaller companies and government grants supporting the earliest stages of research, which are then acquired by medium-sized companies, which in turn are consolidated into large companies. This food chain is fundamentally in doubt based on shrinking Federal spending on research combined with a decline in venture capital support for early-stage start-ups.


2002 ◽  
Vol 1 (3) ◽  
pp. 1-23 ◽  
Author(s):  
Sheng-Cheng Hu ◽  
Vei-Lin Chan

Taiwan became a leading worldwide manufacturer of computer hardware in the 1990s. The purpose of this paper is to review the process that led to the birth and growth of Taiwan's information-communication technology (ICT) industries. We further discuss such factors as research and development, high-tech human capital, venture capital, financial liberalization, and telecommunications liberalization, which have contributed to the success of the ICT industries and the shift in the economy from labor-intensive to capital-intensive and technology-intensive production.


2019 ◽  
Vol 8 (4) ◽  
pp. 2145-2150

The paper discusses real examples of venture capital firms that have reached a high level, as well as start-ups that have not yet managed to become mature companies. The paper presents statistical data on venture investments in the form of tables and graphs for clarity and simplification of the perception of numerical data. The process of evaluating venture capital enterprises is described, which allows you to decide to invest money in a project or abandon such a decision. In the course of the research, scientific, comprehensive literature, periodical informational publications, and Internet resources of various types were used: websites of venture funds, Internet blogs of famous business angels, research articles on venture investment. The choice of diverse literature made it possible to approach the questions of research critically, which helped to ensure an independent assessment. Besides, scientific calculations were used from related fields - marketing, economic psychology, management, which allowed us to consider the topic from different angles, illuminating the subject and object of research from new perspectives. The economic and mathematical model for assessing the impact of venture network actors on the commercialization of innovative products at the regional level consists of the following indicators: advanced manufacturing technologies used; volume of innovative goods, works, services; the number of personnel engaged in research and development; grant of patents; amount of investment; domestic current expenditure on research and development; share of investments in 1 private equity and venture capital fund; share of expenses of the first organization for research and development.


2017 ◽  
Vol 14 (06) ◽  
pp. 1750031 ◽  
Author(s):  
Rudra P. Pradhan ◽  
Rana P. Maradana ◽  
Danish B. Zaki ◽  
Saurav Dash ◽  
Manju Jayakumar ◽  
...  

The paper examines the long-run relationship between venture capital and innovation in the 19 European Economic Area (EEA) countries over the period 1989–2014. We use three different indicators of venture capital (VC), such as VC at early stage investment, VC at later stage investment, and VC total investment, and seven different indicators of innovation, such as patents-residents, patents-nonresidents, patents-total, research and development expenditure, researchers in research and development activities, high-technology exports, and scientific and technical journal articles, to examine this long-run relationship. Using cointegration technique, the study warrants the support of long-run relationship between venture capital and innovation in few cases, typically with reference to a particular VC indicator and innovation indicator. Expending the Granger causality test, the study finds the presence of both bidirectional and unidirectional causality between venture capital and innovation. However, these results vary from country-to-country within the EEA countries, depending upon the types of VC indicator and innovation indicator that we use in a particular empirical exploration process. The policy implication of this study is that the economic policies should recognize the differences in the venture capital and innovation in order to maintain the sustainable development in these EEA countries.


2015 ◽  
Vol 21 (2) ◽  
Author(s):  
Gunter Festel ◽  
Christian Rammer

As in the medical biotechnology area some decades ago, the fast technological development within industrial biotechnology (IB) has caused numerous new ventures. Venture capital (VC) has become a major capital source for these companies and VC investors have particularly allocated financing to research and development (R&D) based companies. Since the early 2000s, the global net stock of VC investments in IB companies has continuously increased over the past 12 years and exceeded 3.5 billion US dollars at the end of 2013. In 2013, the gross amount of VC money was 386 million US dollars distributed to 20 companies corresponding to an average amount of 19.3 million US dollars for each company. The rising capital contribution into the IB sector indicates that it is seen as an attractive investment opportunity for VC investors. Analysing the VC investments by segments shows that there is a strong preference for biofuels and biochemicals. The regional breakdown of VC activities shows that the Americas are the leading region followed by Europe.


Sign in / Sign up

Export Citation Format

Share Document